Schonfeld Strategic Advisors’s Adicet Bio ACET Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ACET Stock Details ACET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.69M	Buy	+195,514	New	+$1.54M	0.01%	1162
2025 Q4	–	Sell	-29,944	Closed	-$388K	–	1994
2025 Q3	$388K	Sell	29,944 -87,562	-75%	-$1.03M	﹤0.01%	1762
2025 Q2	$1.15M	Buy	+117,506	New	+$1.24M	0.01%	1245
2024 Q3	–	Sell	-1,850	Closed	-$35.8K	–	1994
2024 Q2	$35.8K	Sell	1,850 -69,050	-97%	-$1.85M	﹤0.01%	1966
2024 Q1	$2.67M	Buy	70,900 +58,394	+467%	+$2.42M	0.02%	892
2023 Q4	$378K	Buy	+12,506	New	+$273K	﹤0.01%	1366
2023 Q3	–	Sell	-1,081	Closed	-$42K	–	1719
2023 Q2	$42K	Buy	+1,081	New	+$95.4K	﹤0.01%	1831

Other funds holding ACET

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

Schonfeld Strategic Advisors's ACET Position: Q2 2026 in Review

Schonfeld Strategic Advisors opened a new position in Adicet Bio (ACET) in Q2 2026: 195,514 shares worth $1.69M. The stake represents 0.01% of the portfolio and ranks #1162 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in ACET as recently as Q3 2025.

Schonfeld Strategic Advisors first reported a position in ACET in Q2 2023 and has held it in 7 quarters since. The position peaked at $2.67M in Q1 2024. 56 funds tracked by Wall St. Rank hold ACET as of Q2 2026.

Schonfeld Strategic Advisors held 195,514 shares of Adicet Bio worth $1.69M as of Q2 2026.
Adicet Bio was a new Schonfeld Strategic Advisors position in Q2 2026.
Adicet Bio made up 0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #1162 holding.
Schonfeld Strategic Advisors first reported a position in Adicet Bio in Q2 2023 and has held it in 7 quarters since.
Schonfeld Strategic Advisors's Adicet Bio position peaked at $2.67M in Q1 2024.
56 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.